Cancer associated antigen 549 (CA 549) test
Author: Otari Nergadze,
Cancer associated antigen 549 (CA 549) test
The indications for cancer associated antigen 549 (CA 549) test — monitoring of the breast carcinoma and its treatment effect.
Cancer associated antigen 549 (CA 549) is mucin-like glycoprotein with a molecular weight of 400 000-500 000 Da.
Cancer associated antigen 549 (CA 549) normal range is not higher than 11 U/ml. The Level of CA 549 is elevated in patients with breast carcinoma.
According to information content, this breast tumor-associated antigen is no different from other mucin-like markers. Elevated levels of CA 549 tumor marker is observed in benign liver diseases (30%) and sometimes with mastopathies.
See also
- Complete blood count (CBC):
- Urinalysis:
- Cerebrospinal fluid (CSF) analysis
- Biochemical markers of bone remodeling and diseases
- Markers of autoimmune connective tissue diseases (CTDs)
- Antiphospholipid syndrome (APS)
- Lipoprotein(a), Lp(a)
- Semen analysis (sperm count test)
- Tumor markers tests (cancer biomarkers):
- β-2 microglobulin (beta-2)
- Alpha-fetoprotein (AFP)
- Squamous cell carcinoma antigen (SCC)
- S100 protein tumormarker
- Calcitonin
- Mucin-like carcinoma-associated antigen (MCA)
- Neuron-specific enolase (NSE)
- Prostate-specific antigen (PSA) test
- Cancer associated antigen 549 (CA 549)
- CA 19-9, CA 72-4, CA 50, CA 15-3 and CA 125 tumor markers (cancer antigens)
- Carcinoembryonic antigen (CEA)
- Thyroglobulin (Tg)
- Tissue polypeptide antigens (ТРА, TPS)
- Cytokeratin-19 fragment (CYFRA 21-1)
- Human chorionic gonadotrophin (hCG)
